Bio-Techne (TECH) Receivables (2016 - 2025)
Historic Receivables for Bio-Techne (TECH) over the last 16 years, with Q4 2025 value amounting to $184.6 million.
- Bio-Techne's Receivables fell 1529.14% to $184.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $184.6 million, marking a year-over-year decrease of 1529.14%. This contributed to the annual value of $206.9 million for FY2025, which is 1429.94% down from last year.
- Latest data reveals that Bio-Techne reported Receivables of $184.6 million as of Q4 2025, which was down 1529.14% from $183.9 million recorded in Q3 2025.
- Bio-Techne's Receivables' 5-year high stood at $241.4 million during Q2 2024, with a 5-year trough of $145.4 million in Q2 2021.
- Moreover, its 5-year median value for Receivables was $203.3 million (2022), whereas its average is $196.5 million.
- Per our database at Business Quant, Bio-Techne's Receivables surged by 3434.42% in 2021 and then tumbled by 1778.86% in 2025.
- Bio-Techne's Receivables (Quarter) stood at $152.9 million in 2021, then grew by 20.84% to $184.8 million in 2022, then increased by 12.28% to $207.5 million in 2023, then rose by 5.06% to $217.9 million in 2024, then dropped by 15.29% to $184.6 million in 2025.
- Its Receivables stands at $184.6 million for Q4 2025, versus $183.9 million for Q3 2025 and $206.9 million for Q2 2025.